NELSEN ROBERT
SEC CIK 1219042 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PRME | Prime Medicine, Inc. | Dir, 10% | 6.23M | $43.60M | — | 4 | 2022-10-24 | 2025-08-01 |
| RAPP | Rapport Therapeutics, Inc. | 10% | 3.73M | — | — | 1 | 2024-06-10 | 2024-06-10 |
| VIR | Vir Biotechnology, Inc. | Dir, 10% | 584.1K | — | — | 26 | 2021-07-01 | 2024-05-30 |
| SANA | Sana Biotechnology, Inc. | Dir, 10% | 10.67M | $10.00M | — | 5 | 2022-04-05 | 2024-02-08 |
| NMRA | Neumora Therapeutics, Inc. | 10% | 3.83M | $28.37M | — | 5 | 2023-09-19 | 2023-09-28 |
Most active insiders at PRME, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| No open-market trades in the last year. | ||||
NELSEN ROBERT made no open-market trades at PRME in the last 12 months.
Transactions 41
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-08-01 | 2025-08-01 | PRME | Prime Medicine, Inc. | NELSEN ROBERT | Dir, 10% | P - Purchase | $3.30 | +3.03M | 6.23M | +95% | +$10.00M |
| DI | 2024-06-10 | 2024-06-10 | RAPP | Rapport Therapeutics, Inc. | NELSEN ROBERT | 10% | C - Cnv Deriv | $0.00 | +3.73M | 3.73M | New | $0 |
| D | 2024-06-03 | 2024-05-30 | VIR | Vir Biotechnology, Inc. | NELSEN ROBERT | Dir | A - Grant | $0.00 | +8,000 | 584.1K | +1% | $0 |
| I | 2024-02-20 | 2024-02-15 | PRME | Prime Medicine, Inc. | NELSEN ROBERT | Dir, 10% | P - Purchase | $6.25 | +3.20M | 3.20M | New | +$20.00M |
| MI | 2024-02-12 | 2024-02-08 | SANA | Sana Biotechnology, Inc. | NELSEN ROBERT | Dir, 10% | P - Purchase | $5.50 | +1.82M | 10.67M | +21% | +$10.00M |
| MI | 2023-09-29 | 2023-09-28+ | NMRA | Neumora Therapeutics, Inc. | NELSEN ROBERT | 10% | P - Purchase | $13.68 | +76.5K | 3.83M | +2% | +$1.05M |
| MI | 2023-09-27 | 2023-09-26+ | NMRA | Neumora Therapeutics, Inc. | NELSEN ROBERT | 10% | P - Purchase | $11.97 | +58.5K | 3.78M | +2% | +$700.5K |
| MI | 2023-09-25 | 2023-09-22+ | NMRA | Neumora Therapeutics, Inc. | NELSEN ROBERT | 10% | P - Purchase | $11.19 | +100.7K | 3.66M | +3% | +$1.13M |
| DMI | 2023-09-20 | 2023-09-19 | NMRA | Neumora Therapeutics, Inc. | NELSEN ROBERT | 10% | C - Cnv Deriv | — | +17.42M | 684.2K | New | — |
| DI | 2023-09-20 | 2023-09-19 | NMRA | Neumora Therapeutics, Inc. | NELSEN ROBERT | 10% | P - Purchase | $17.00 | +1.50M | 3.62M | +71% | +$25.50M |
| D | 2023-05-24 | 2023-05-22 | VIR | Vir Biotechnology, Inc. | NELSEN ROBERT | Dir, 10% | A - Grant | $0.00 | +6,027 | 576.1K | +1% | $0 |
| 2023-01-06 | 2023-01-05 | SANA | Sana Biotechnology, Inc. | NELSEN ROBERT | Dir, 10% | A - Grant | $0.00 | +536 | 1,353 | +66% | $0 | |
| DMI | 2022-10-26 | 2022-10-24 | PRME | Prime Medicine, Inc. | NELSEN ROBERT | Dir, 10% | C - Cnv Deriv | — | +11.47M | 16.1K | New | — |
| DMI | 2022-10-26 | 2022-10-24 | PRME | Prime Medicine, Inc. | NELSEN ROBERT | Dir, 10% | P - Purchase | $17.00 | +800.0K | 6.13M | +15% | +$13.60M |
| 2022-10-06 | 2022-10-05 | SANA | Sana Biotechnology, Inc. | NELSEN ROBERT | Dir, 10% | A - Grant | $0.00 | +321 | 817 | +65% | $0 | |
| MI | 2022-09-07 | 2022-09-02+ | VIR | Vir Biotechnology, Inc. | NELSEN ROBERT | Dir, 10% | J - Other | $0.00 | -996.6K | 5.63M | -15% | $0 |
| M | 2022-09-07 | 2022-09-02+ | VIR | Vir Biotechnology, Inc. | NELSEN ROBERT | Dir, 10% | J - Other | $0.00 | +55.0K | 570.1K | +11% | $0 |
| M | 2022-09-01 | 2022-08-30+ | VIR | Vir Biotechnology, Inc. | NELSEN ROBERT | Dir, 10% | J - Other | $0.00 | +55.0K | 515.1K | +12% | $0 |
| MI | 2022-09-01 | 2022-08-30+ | VIR | Vir Biotechnology, Inc. | NELSEN ROBERT | Dir, 10% | J - Other | $0.00 | -996.6K | 8.14M | -11% | $0 |
| MI | 2022-08-26 | 2022-08-24+ | VIR | Vir Biotechnology, Inc. | NELSEN ROBERT | Dir, 10% | J - Other | $0.00 | -996.6K | 6.71M | -13% | $0 |
| M | 2022-08-26 | 2022-08-24+ | VIR | Vir Biotechnology, Inc. | NELSEN ROBERT | Dir, 10% | J - Other | $0.00 | +55.0K | 460.2K | +14% | $0 |
| MI | 2022-08-22 | 2022-08-18 | VIR | Vir Biotechnology, Inc. | NELSEN ROBERT | Dir, 10% | J - Other | $0.00 | -498.3K | 23.8K | -95% | $0 |
| 2022-08-22 | 2022-08-18 | VIR | Vir Biotechnology, Inc. | NELSEN ROBERT | Dir, 10% | J - Other | $0.00 | +27.5K | 405.2K | +7% | $0 | |
| MI | 2022-08-16 | 2022-08-12+ | VIR | Vir Biotechnology, Inc. | NELSEN ROBERT | Dir, 10% | J - Other | $0.00 | -1.49M | 9.55M | -14% | $0 |
| M | 2022-08-16 | 2022-08-12+ | VIR | Vir Biotechnology, Inc. | NELSEN ROBERT | Dir, 10% | J - Other | $0.00 | +82.5K | 350.2K | +31% | $0 |
| 2022-07-07 | 2022-07-05 | SANA | Sana Biotechnology, Inc. | NELSEN ROBERT | Dir | A - Grant | $0.00 | +266 | 496 | +116% | $0 | |
| MI | 2022-06-10 | 2022-06-08 | VIR | Vir Biotechnology, Inc. | NELSEN ROBERT | Dir, 10% | J - Other | $0.00 | -498.3K | 10.11M | -5% | $0 |
| 2022-06-10 | 2022-06-08 | VIR | Vir Biotechnology, Inc. | NELSEN ROBERT | Dir, 10% | J - Other | $0.00 | +27.5K | 295.2K | +10% | $0 | |
| MI | 2022-06-06 | 2022-06-02 | VIR | Vir Biotechnology, Inc. | NELSEN ROBERT | Dir, 10% | J - Other | $0.00 | -500.0K | 10.40M | -5% | $0 |
| 2022-06-06 | 2022-06-02 | VIR | Vir Biotechnology, Inc. | NELSEN ROBERT | Dir, 10% | J - Other | $0.00 | +29.2K | 283.1K | +11% | $0 | |
| D | 2022-05-25 | 2022-05-23 | VIR | Vir Biotechnology, Inc. | NELSEN ROBERT | Dir, 10% | A - Grant | $0.00 | +6,405 | 254.0K | +3% | $0 |
| A | 2022-05-10 | 2021-12-20 | VIR | Vir Biotechnology, Inc. | NELSEN ROBERT | Dir, 10% | J - Other | $0.00 | +102.0K | 247.5K | +70% | $0 |
| 2022-04-06 | 2022-04-05 | SANA | Sana Biotechnology, Inc. | NELSEN ROBERT | Dir | A - Grant | $0.00 | +230 | 230 | New | $0 | |
| MI | 2021-12-22 | 2021-12-20 | VIR | Vir Biotechnology, Inc. | NELSEN ROBERT | Dir, 10% | J - Other | $0.00 | -1.75M | 10.68M | -14% | $0 |
| 2021-12-22 | 2021-12-20 | VIR | Vir Biotechnology, Inc. | NELSEN ROBERT | Dir, 10% | J - Other | $0.00 | +102.0K | 244.2K | +72% | $0 | |
| MI | 2021-12-01 | 2021-11-29 | VIR | Vir Biotechnology, Inc. | NELSEN ROBERT | Dir, 10% | J - Other | $0.00 | -500.0K | 9.00M | -5% | $0 |
| 2021-12-01 | 2021-11-29 | VIR | Vir Biotechnology, Inc. | NELSEN ROBERT | Dir, 10% | J - Other | $0.00 | +29.2K | 142.1K | +26% | $0 | |
| 2021-11-24 | 2021-11-22 | VIR | Vir Biotechnology, Inc. | NELSEN ROBERT | Dir, 10% | J - Other | $0.00 | +29.2K | 113.0K | +35% | $0 | |
| MI | 2021-11-24 | 2021-11-22 | VIR | Vir Biotechnology, Inc. | NELSEN ROBERT | Dir, 10% | J - Other | $0.00 | -500.0K | 9.22M | -5% | $0 |
| 2021-07-06 | 2021-07-01 | VIR | Vir Biotechnology, Inc. | NELSEN ROBERT | Dir, 10% | J - Other | $0.00 | +47.9K | 83.8K | +133% | $0 | |
| MI | 2021-07-06 | 2021-07-01 | VIR | Vir Biotechnology, Inc. | NELSEN ROBERT | Dir, 10% | J - Other | $0.00 | -4.00M | 12.23M | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations